BSE: SANOFI - Sanofi India Limited

半年間の収益性: -12.85%

プロモーションスケジュール Sanofi India Limited

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors.

さらに詳しく
It also exports its products to approximately 35 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

ISIN INE058A01010
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 1.71
Дивиденд ао 68.21
Сайт https://www.sanofiindialtd.com
Цена ао 5592.35
1日あたりの価格変動: -0.4488% (5592.35)
週ごとの価格変動: -6.84% (5976.1)
月ごとの料金変更: -10.28% (6205.25)
3ヶ月間の価格変動: -18.95% (6869)
半年間の価格変動: -12.85% (6388.45)
年間の価格変動: -32.38% (8233.25)
3年間の価格推移: -25.95% (7518.15)
5年間の価格推移: -20.95% (7042.75)
10年間の価格推移: 0% (5567.25)
年初からの価格変動: -9.08% (6123.05)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 6.55 1
P/BV 18.17 1
P/E 30.59 5
EV/EBITDA 17.69 6
合計: 4.63

効率

名前 意味 学年
ROA, % 35.16 9
ROE, % 59.39 10
合計: 5.83

配当金

名前 意味 学年
Div yield, % 1.51 3.78
DSI 0.8571 8.57
合計: 4.94

義務

名前 意味 学年
Debt/EBITDA 0.026 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % -8.24 0
収益性 Ebitda, % 20.55 4
収益性 EPS, % 50.5 7
合計: 3.4
さらに詳しく

ETF 共有, % 年間の利益率, % 配当金, %
iShares MSCI India Small-Cap ETF 0.16695 0.4625 0.96163
SPDR S&P Emerging Markets Small Cap ETF 0.07114 5.46 3.03583
iShares MSCI Emerging Markets Small-Cap ETF 0.04483 7.67 2.7853
Avantis Emerging Markets Value ETF 0.03441 14.12 4.22231
Avantis Responsible Emerging Markets Equity ETF 0.02777 17.6 3.1719
Vanguard FTSE All-World ex-US Small-Cap ETF 0.02 9.39 3.09932
Avantis Emerging Markets Equity ETF 0.01484 8.77 3.60513
Dimensional Emerging Markets Core Equity 2 ETF 0.0079 15.96 3.34087
Dimensional World ex U.S. Core Equity 2 ETF 0.00469 13.06 3.62488
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.00447 12.46 3.59676

スーパーバイザー 役職 支払い 生年
Mr. Rodolfo Hrosz MD & Director 17.85M 1967 (58 年)
Mr. M. K. Narayanaswamy B.Com.,A.I.C.W.A. Senior Director of Accounting & Taxation N/A 1955 (70 年)
Mr. Sanjay V. Chavan Head of Country Procurement - India N/A 1962 (63 年)
Ms. Surabhi Kaur People & Culture Director N/A
Ms. Renee Amonkar Additional Whole Time Director N/A
Mr. Rachid Ayari CFO & Whole Time Director N/A
Ms. Flovie Martins Head of Corporate Communications & Corporate Social Responsibility
Nakul Verma Senior Director of Public Affairs
Yasmin Shenoy Senior Director of Regulatory Affairs
Mr. N. Suresh Babu Sales & Customer Engagement Head - Diabetes and Senior Director of Diabetes

住所: India, Mumbai, Sanofi House - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.sanofiindialtd.com